Kewaunee Scientific (NASDAQ:KEQU) Cut to “Hold” at StockNews.com

Kewaunee Scientific (NASDAQ:KEQU) was downgraded by analysts at StockNews.com from a “buy” rating to a “hold” rating in a report issued on Sunday.

Kewaunee Scientific Trading Up 2.2 %

NASDAQ KEQU opened at $43.70 on Friday. The firm’s 50 day moving average price is $34.89 and its two-hundred day moving average price is $41.72. The company has a debt-to-equity ratio of 0.48, a quick ratio of 2.00 and a current ratio of 2.53. Kewaunee Scientific has a twelve month low of $16.51 and a twelve month high of $55.62. The stock has a market cap of $125.42 million, a price-to-earnings ratio of 7.01 and a beta of 0.73.

Kewaunee Scientific (NASDAQ:KEQU) last issued its quarterly earnings results on Wednesday, September 11th. The technology company reported $0.93 earnings per share for the quarter. The business had revenue of $48.39 million for the quarter. Kewaunee Scientific had a return on equity of 25.87% and a net margin of 9.13%.

Institutional Investors Weigh In On Kewaunee Scientific

Institutional investors have recently modified their holdings of the stock. Barclays PLC acquired a new position in shares of Kewaunee Scientific in the third quarter worth $121,000. Geode Capital Management LLC increased its position in Kewaunee Scientific by 8.9% in the 3rd quarter. Geode Capital Management LLC now owns 23,784 shares of the technology company’s stock worth $792,000 after purchasing an additional 1,941 shares during the last quarter. State Street Corp purchased a new stake in shares of Kewaunee Scientific during the 3rd quarter worth about $266,000. De Lisle Partners LLP lifted its holdings in shares of Kewaunee Scientific by 36.6% during the 3rd quarter. De Lisle Partners LLP now owns 42,958 shares of the technology company’s stock valued at $1,446,000 after buying an additional 11,511 shares during the last quarter. Finally, Ritholtz Wealth Management grew its stake in shares of Kewaunee Scientific by 24.6% in the 3rd quarter. Ritholtz Wealth Management now owns 10,913 shares of the technology company’s stock valued at $363,000 after buying an additional 2,156 shares in the last quarter. Institutional investors and hedge funds own 32.69% of the company’s stock.

About Kewaunee Scientific

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.